Oncolytics Biotech (ONCY) Deferred Taxes (2009 - 2010)

Oncolytics Biotech (ONCY) has reported Deferred Taxes for 2 consecutive years, with $2.2 million the latest figure, recorded in Q4 2010.

• On a quarterly basis, Deferred Taxes changed N/A year-over-year to $2.2 million in Q4 2010; TTM through Dec 2010 was $5.5 million, a 396.05% increase from a year earlier, with the FY2010 full-year figure at $1.1 million, changed 0.0% from the prior year.
• Deferred Taxes was $2.2 million for Q4 2010 at Oncolytics Biotech, up from $1.1 million in the prior quarter.
• Over five years, Deferred Taxes peaked at $2.2 million in Q4 2010 and troughed at -$1.1 million in Q1 2009.